ITGR — Integer Holdings Corporation
$126.70
+$0.28 (+0.22%)
Integer Holdings Corporation operates as a medical device contract development and manufacturing company in the United States, Costa Rica, Puerto Rico, Ireland, and internationally. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures.
Market Cap
$4.31B
Forward P/E
18.4x
52-Week Range
N/A
ITGR Price History
Revenue vs. Net Income
$1.9B
Revenue · FY2025
Annual. Net margin is shown under each year.
Free Cash Flow
$105M
FCF · FY2025
Annual. FCF margin is shown under each year.
Return on Capital Employed (ROCE)
5.1%
ROCE · FY2025
Annual. Green above 0%, red below. Dashed line marks the 15% compounder threshold.
Total Assets vs. Total Liabilities
2.0x
Assets ÷ liabilities · FY2025
Annual. What the company owns against what it owes. Assets ÷ liabilities is shown under each year.
CapEx as % of Revenue
4.9%
CapEx · FY2025
Annual. Green at or under the 5% maximum target, red above it.
Shares Outstanding
-0.2%
Net buyback · FY2025
Annual diluted shares. Under each year: the change on the previous year (green = buyback, amber = dilution).
